Тавсифи Маҳсулот
Тазриқи доксорубицин гидрохлориди липосома can be used for low CD4 (3) and has a broad visceral disease of skin mucosa viscera and related to HIV/AIDS AIDS – KS patients. Тазриқи доксорубицин гидрохлориди липосома can be used as First-line of systemic chemotherapy drugs or as second-line chemotherapy drugs for treatment with progression of AIDS-KS patients, also can be used to can’t tolerate the following more than two drug combination chemotherapy patients: vincristine, bleomycin and doxorubicin.
Номи маводи мухаддир
Номи умумӣ. Доксорубицин гидрохлориди липосома Инжection
English Name. Doxorubicin Hydrochloride Liposome Injection
Molecular Formular. C27H29NO11 HCl
Вазни молекулавӣ. 579,99
Тазриқи доксорубицин гидрохлориди липосома Тавсифи
This product is red semitransparent mixed suspension.
Тазриқи доксорубицин гидрохлориди липосома Нишондодҳо
1. This product can be used for low CD4 (3) and has a broad visceral disease of skin mucosa viscera and related to HIV/AIDS AIDS – KS patients.
2. This product can be used as First-line of systemic chemotherapy drugs or as second-line chemotherapy drugs for treatment with progression of AIDS-KS patients, also can be used to can’t tolerate the following more than two drug combination chemotherapy patients:vincristine, bleomycin and doxorubicin (or other anthracycline Антибиотикҳо).
Мушаххасот
20 мг/10 мл
Бастабандӣ
1 шиша / қуттии
Тайёрй
тазриқ
